Filing Details
- Accession Number:
- 0001209191-16-149452
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-10 18:12:32
- Reporting Period:
- 2016-11-09
- Filing Date:
- 2016-11-10
- Accepted Time:
- 2016-11-10 18:12:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1429560 | Trevena Inc | TRVN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1638989 | L. Carrie Bourdow | C/O Trevena, Inc., 1018 West 8Th Avenue, Suite A King Of Prussia PA 19406 | Svp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-11-09 | 4,000 | $4.34 | 4,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.32 - $4.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- These shares are held by the Reporting Person jointly with her spouse.
Billionaire Hedge Funds
